A Double-blind and Randomized Trial of Ginkgo Biloba Extract Added to Risperidone in Treatment-naive First-episode Schizophrenia.
Phase of Trial: Phase III
Latest Information Update: 26 Nov 2015
At a glance
- Drugs EGb 761 (Primary) ; Risperidone
- Indications Schizophrenia
- Focus Therapeutic Use
- 01 Aug 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 04 Feb 2012 New trial record